By: Quiver DiscussionTracker Posted: 4 days, 11 hours ago / Aug. 23, 2025 2:05 p.m. UTC Recent discussions on X about Tenet...
Corporation
DURECT's lead asset, Larsucosterol, is an epigenetic modulator with FDA Breakthrough Therapy Designation Potential to be the first FDA-approved therapeutic...
At CES 2025, Intel unveils new adaptive control solution, next-gen discrete graphics and AWS...
